Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Less than half of patients with cardiometabolic disease consistently take prescribed medications. While health insurers and some delivery organizations use claims to measure adherence, most clinicians do not have access during routine interactions. Self-reported scales exist, but their practical utility is often limited by length or cost. By contrast, the accuracy of a new 3-item self-reported measure has been demonstrated in individuals with HIV. We evaluated its concordance with claims-based adherence measures in cardiometabolic disease.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am Heart J

Title: American heart journal

Publisher: Elsevier BV

ISSN (Electronic): 1097-6744

ISSN (Print): 0002-8703

Publication date (Electronic): October 2020

Volume: 228

Affiliations

[1 ] Center for Healthcare Delivery Sciences (C4HDS), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Electronic address: jlauffenburger@bwh.harvard.edu.

[2 ] Center for Healthcare Delivery Sciences (C4HDS), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

[3 ] Atrius Health, Newton, MA.

[4 ] Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

[5 ] Division of General Internal Medicine and Department of Health Care Policy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

[6 ] Western University of Health Sciences, Pomona, CA, USA; VA Greater Los Angeles Healthcare System, Los Angeles, CA; Institute for Health Policy, Management and Evaluation, University of Toronto; and ICES, University Health Network, Toronto, Canada.

[7 ] Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Article

Publisher Item ID: S0002-8703(20)30192-7 Mid ID: NIHMS1608234

DOI: 10.1016/j.ahj.2020.06.012

PMC ID: 7508975

PubMed ID: 32768690

SO-VID: 0ef5c1fe-fff9-4923-add1-bc21de2c40a4

History

Data availability:

Comments

Comment on this article

scite_

Cited by 8

See all cited by